Open Beta
TREN
MetriLume
TREN

US marketsBMRN

SEC-sourced researchBeta

BMRN

BIOMARIN PHARMACEUTICAL INC

Company comparison ↗

Data passport

CIK
0001048477
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 2,419,226,000.0000 USD; December 2024: 2,853,915,000.0000 USD; December 2025: 3,221,253,000.0000 USD3.2B USD0 USD0December 2023December 2024December 2025
BMRN · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20232,419,226,000.0000Feb 26, 2026
December 20242,853,915,000.0000Feb 26, 2026
December 20253,221,253,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20253,221,253,000.0000348,901,000.0000827,994,000.00007,594,022,000.00001,507,023,000.0000Feb 26, 2026
December 20242,853,915,000.0000426,859,000.0000572,841,000.00006,988,940,000.00001,330,950,000.0000Feb 26, 2026
December 20232,419,226,000.0000167,645,000.0000159,259,000.0000——Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$3.22BDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$2.85BDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss$348.9MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$827.99MDecember 2025Feb 26, 202610-K
Total assetsAssets$7.59BDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$1.51BDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗